| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 55 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 55 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 55 |
| 3 | BUSULFAN | 38 |
| 4 | ETOPOSIDE | 34 |
| 5 | METHOTREXATE SODIUM | 15 |
| 6 | METHOTREXATE | 14 |
| 7 | CYTARABINE | 12 |
| 8 | CISPLATIN | 11 |
| 9 | FINASTERIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETIBEGLOGENE AUTOTEMCEL | 3 | 0.0536 |
| 1 | CLOBETASOL PROPIONATE CREAM USP, 0.05% | 1 | 0.0101 |
| 2 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 3 | 0.0029 |
| 3 | BUSULFAN | 38 | 0.0024 |
| 4 | IDARUBICIN HYDROCHLORIDE | 2 | 0.0017 |
| 5 | THIOGUANINE | 3 | 0.0014 |
| 6 | MITOTANE | 2 | 0.0011 |
| 7 | DACTINOMYCIN | 2 | 0.0009 |
| 8 | PSYLLIUM HUSK | 1 | 0.0007 |
| 9 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 72 |
| 1 | Topoisomerase Inhibitor [EPC] | 34 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 12 |
| 4 | 5-alpha Reductase Inhibitor [EPC] | 11 |
| 5 | Platinum-based Drug [EPC] | 11 |
| 6 | Recombinant Human Growth Hormone [EPC] | 8 |
| 7 | Corticosteroid [EPC] | 7 |
| 8 | Androgen [EPC] | 6 |
| 9 | Progesterone [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 2 | 0.0009 |
| 1 | Topoisomerase Inhibitor [EPC] | 34 | 0.0004 |
| 2 | Recombinant Human Growth Hormone [EPC] | 8 | 0.0004 |
| 3 | Alkylating Drug [EPC] | 72 | 0.0003 |
| 4 | Progesterone [EPC] | 6 | 0.0003 |
| 5 | Androgen [EPC] | 6 | 0.0002 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 7 | Bile Acid [EPC] | 3 | 0.0001 |
| 8 | 5-alpha Reductase Inhibitor [EPC] | 11 | 0.0001 |
| 9 | Iron Chelator [EPC] | 3 | 0.0001 |